Article
Successful every-other-day liothyronine therapy for severe resistance to thyroid hormone beta with a novel THRB mutation; case report.
BMC endocrine disorders - 12 Jan 2016
Maruo Yoshihiro, Mori Asami, Morioka Yoriko, Sawai Chihiro, Mimura Yu, Matui Katsuyuki, Takeuchi Yoshihiro
Abstract excerpt
BACKGROUND: Resistance to thyroid hormone beta (RTHβ) is a rare and usually dominantly inherited syndrome caused by mutations of the thyroid hormone receptor β gene (THRB). In severe cases, it is rarely challenging to control manifestations using daily therapeutic replacement of thyroid hormone. CASE PRESENTATION: The present case study concerns an 8-year-old Japanese girl with a severe phenotype of RTH (TSH,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
